Kyle Mikson

Q: What is Kyle Mikson's success rate?

Kyle Mikson currently has a success rate of 97.45190467790673.

Q: What is the average return of Kyle Mikson's calls?

Their stock ratings have generated an average return of 42.48902102782707.

Canaccord Genuity | Healthcare

Kyle Mikson is an analyst from Canaccord Genuity specializing in the Healthcare sector. Ranked #320 out of 4771 analysts, they have issued 64 stock ratings with a success rate of 97.45% and an average return of 42.49%.

Kyle Mikson has a well-established track record, with 64 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 97.45% and an average return of 42.49%, underscoring their expertise and ability to identify winning opportunities for investors.

#320

Out of 4771

Total Ratings

+97.45%

Success Rate

+42.49%

Average Return

Recent Ratings Analysis

CDNA

Buy

Sep 02, 2026

Target

$65.00

Current

$50.02

Performance

0.85%

Kyle Mikson rated CDNA as Buy on Sep 02, 2026, setting a price target of 65. Shares have remained stable near 50.02, leaving the 65 target still in play.

BLLN

Buy

Sep 02, 2026

Target

$120.00

Current

$98.51

Performance

2.45%

On Sep 02, 2026, BLLN was given a Buy rating by Kyle Mikson, with a target price of 120. The stock traded sideways with a 2.45% move, keeping the bullish thesis unresolved.

WGS

Buy

Aug 04, 2026

Target

$90.00

Current

$83.96

Performance

18.42%

WGS received a Buy rating from Kyle Mikson on Aug 04, 2026, aiming for 90. Momentum has favored the Buy call, with shares climbing from 83.96 to 83.96, rewarding those who trusted the recommendation.

ILMN

Hold

Aug 03, 2026

Target

$205.00

Current

$201.27

Performance

1.57%

On Aug 03, 2026, Kyle Mikson published a Hold outlook on ILMN, with a target of 205. Sideways action left the Hold view intact, with no major move since 201.27.

VCYT

Hold

Aug 03, 2026

Target

$50.00

Current

$42.03

Performance

-6.29%

Kyle Mikson on Aug 03, 2026 assigned VCYT a Hold rating, with a price target of 50. The call successfully avoided chasing as shares lost 6.29%.

NTRA

Buy

Jul 14, 2026

Target

$330.00

Current

$326.14

Performance

19.61%

On Jul 14, 2026, Kyle Mikson reaffirmed NTRA with a Buy rating, targeting 330. The recommendation was supported by strong follow-through as the stock rose from 326.14 to 326.14.

TXG

Buy

Jul 14, 2026

Target

$50.00

Current

$66.38

Performance

44.97%

TXG was rated Buy by Kyle Mikson on Jul 14, 2026, with a price objective of 50. A bullish response from the market helped close the gap of -16.38 to the target.

TWST

Buy

Jul 14, 2026

Target

$120.00

Current

$126.85

Performance

37.09%

On Jul 14, 2026, Kyle Mikson initiated coverage on TWST with a Buy rating and target of 120. The stock’s climb of 37.09% since the call highlights the foresight in the rating.

GH

Buy

Jul 14, 2026

Target

$205.00

Current

$159.03

Performance

-0.67%

Kyle Mikson issued a Buy recommendation for GH on Jul 14, 2026, price target set at 205. The target of 205 remains in play, though confirmation will depend on future moves.

BDSX

Buy

Jun 18, 2026

Target

$27.00

Current

$26.04

Performance

54.91%

On Jun 18, 2026, BDSX was evaluated by Kyle Mikson, who gave a Buy rating and target of 27. This case illustrates how a timely bullish rating can translate into tangible gains of 54.91%.

SEER

Buy

May 04, 2026

Target

$4.00

Current

$1.93

Performance

-1.03%

Kyle Mikson rated SEER as Buy on May 04, 2026, setting a price target of 4. Shares have remained stable near 1.93, leaving the 4 target still in play.

XGN

Buy

Apr 20, 2026

Target

$8.00

Current

$6.97

Performance

133.11%

On Apr 20, 2026, XGN was given a Buy rating by Kyle Mikson, with a target price of 8. The stock rallied 133.11% after the rating, narrowing the gap to the target of 8 and validating the bullish stance.

CSTL

Buy

Apr 20, 2026

Target

$40.00

Current

$32.32

Performance

28.46%

CSTL received a Buy rating from Kyle Mikson on Apr 20, 2026, aiming for 40. Momentum has favored the Buy call, with shares climbing from 32.32 to 32.32, rewarding those who trusted the recommendation.

QTRX

Hold

Apr 20, 2026

Target

$4.00

Current

$2.50

Performance

-24.24%

On Apr 20, 2026, Kyle Mikson published a Hold outlook on QTRX, with a target of 4. Weakness in the stock, now at 2.5, supported the conservative rating.

RGEN

Hold

Apr 20, 2026

Target

$145.00

Current

$164.68

Performance

24.77%

Kyle Mikson on Apr 20, 2026 assigned RGEN a Hold rating, with a price target of 145. Shares outperformed expectations, climbing 24.77% despite the neutral view.

CAI

Hold

Mar 13, 2026

Target

$22.00

Current

$24.04

Performance

32.45%

On Mar 13, 2026, Kyle Mikson reaffirmed CAI with a Hold rating, targeting 22. Market strength beyond 24.04 went further than the conservative outlook suggested.

QSI

Hold

Mar 05, 2026

Target

$1.50

Current

$0.74

Performance

—

QSI was rated Hold by Kyle Mikson on Mar 05, 2026, with a price objective of 1.5. Flat performance suggests the Hold view was reasonable.

GRAL

Buy

Feb 20, 2026

Target

$105.00

Current

$77.56

Performance

54.47%

On Feb 20, 2026, Kyle Mikson initiated coverage on GRAL with a Buy rating and target of 105. The stock’s climb of 54.47% since the call highlights the foresight in the rating.

TEM

Buy

Dec 22, 2025

Target

$95.00

Current

$58.74

Performance

-10.89%

Kyle Mikson issued a Buy recommendation for TEM on Dec 22, 2025, price target set at 95. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

EXAS

Hold

Nov 25, 2025

Target

$105.00

Current

$104.91

Performance

3.74%

On Nov 25, 2025, EXAS was evaluated by Kyle Mikson, who gave a Hold rating and target of 105. Hold sentiment was validated by subdued trading with no breakout beyond 104.91.

PACB

Buy

Apr 10, 2025

Target

$3.00

Current

$1.27

Performance

-7.97%

Kyle Mikson rated PACB as Buy on Apr 10, 2025, setting a price target of 3. The stock has underperformed, dropping 7.97% despite the bullish target of 3.

AKYA

Buy

Nov 15, 2024

Target

$3.50

Current

$1.29

Performance

-46.47%

On Nov 15, 2024, AKYA was given a Buy rating by Kyle Mikson, with a target price of 3.5. Despite the Buy call, shares fell from 1.29 to 1.29, challenging the optimistic stance.

TTOO

Hold

Jul 30, 2024

Target

$5.00

Current

$0.00

Performance

-99.98%

TTOO received a Hold rating from Kyle Mikson on Jul 30, 2024, aiming for 5. The Hold stance proved prudent, with the market softening by 99.98%.

Frequency Asked Questions

Who is Kyle Mikson?

Kyle Mikson is an analyst from Canaccord Genuity specializing in the Healthcare sector.

What is Kyle Mikson's success rate?

Kyle Mikson currently has a success rate of +97.45%.

How many ratings has Kyle Mikson issued?

Kyle Mikson has issued 64 stock ratings so far.

What is the average return of Kyle Mikson's calls?

Their stock ratings have generated an average return of +42.49%.

What is Kyle Mikson's ranking?

Kyle Mikson is ranked #320 out of 4771 analysts.

What types of ratings does Kyle Mikson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kyle Mikson?

You can follow Kyle Mikson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kyle Mikson?

Their latest rating was a Buy on CDNA issued on 2026-09-02.